ASPEN PARK PHARMACEUTICALS, INC. — Form D
ASPEN PARK PHARMACEUTICALS, INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-03-31. The offering totals $2.0M, of which $1.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-03-31
- Form: D
- Accession: 0001670870-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.3M
- Remaining: $750K
- Investors: 9
- Date of first sale: 2016-03-30
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-260428
Issuer
- Name: ASPEN PARK PHARMACEUTICALS, INC.
- CIK: 0001620965
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 944 PARK AVENUE, NEW YORK, NY, 10028
- Phone: 914-552-2651
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Harry S Fisch, M.D. | Director | New York, NY |
| Mitchell S Steiner | Director | Chicago, IL |
| Harry S Fisch, M.D. | Executive Officer | New York, NY |
| Mitchell S Steiner | Executive Officer | Chicago, IL |
| Harry S Fisch, MD | Director | New York, NY |
| Harry S Fisch, MD | Executive Officer | New York, NY |
Other filings by this issuer (1)
More